Your browser doesn't support javascript.
loading
The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson's Disease by Inhibiting the NF-κB/NLRP3 Pathway.
Liu, Shuhan; Wang, Shengxiang; Gu, Runze; Che, Na; Wang, Jing; Cheng, Jinbo; Yuan, Zengqiang; Cheng, Yong; Liao, Yajin.
Afiliação
  • Liu S; Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China.
  • Wang S; Key Laboratory of Ecology and Environment in Minority Areas (Minzu University of China), National Ethnic Affairs Commission, Beijing, China.
  • Gu R; Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China.
  • Che N; Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China.
  • Wang J; Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China.
  • Cheng J; Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China.
  • Yuan Z; Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China.
  • Cheng Y; Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China.
  • Liao Y; The Brain Science Center, Beijing Institute of Basic Medical Sciences, Beijing, China.
Front Pharmacol ; 13: 847605, 2022.
Article em En | MEDLINE | ID: mdl-35721113
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article